The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Open accessAbstract
The tumor development and metastasis are closely related to the structure and function of the tumor microenvironment (TME). Recently, TME modulation strategies have attracted much attention in cancer immunotherapy. Despite the preliminary success of immunotherapeutic agents, their therapeutic effects have been restricted by the limited retention time of drugs in TME. Compared with traditional delivery systems, nanoparticles with unique physical properties and elaborate design can efficiently penetrate TME and specifically deliver to the major components in TME. In this review, we briefly introduce the substitutes of TME including dendritic cells, macrophages, fibroblasts, tumor vasculature, tumor-draining lymph nodes and hypoxic state, then review various nanoparticles targeting these components and their applications in tumor therapy. In addition, nanoparticles could be combined with other therapies, including chemotherapy, radiotherapy, and photodynamic therapy, however, the nanoplatform delivery system may not be effective in all types of tumors due to the heterogeneity of different tumors and individuals. The changes of TME at various stages during tumor development are required to be further elucidated so that more individualized nanoplatforms could be designed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Several nanodrugs, such as Doxil [25] and Abraxane [26], have been approved by the FDA for clinical use.”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046 · cited 1×
“However, a number of molecules found in TME as well as hypoxic environment and lactic acid inhibit the functions of cDCs [29,30].”
BackgroundMolecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Self-citationA review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Microenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Tumor microenvironment and therapeutic response
Wu, T., & Dai, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.01.043 · Cited by 1,802
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Zhang, C., Bu, W., Ni, D., Zhang, S., Li, Q., Yao, Z., Zhang, J., Yao, H., Wang, Z., & Shi, J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510031 · Cited by 1,269
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241 · cited 1×
“Given these two activated states, macrophages are regarded as “a double-edged sword” with both pro-tumor and anti-tumor ability [47, 48].”
BackgroundAltered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Gettinger, S. N., Horn, L., Gandhi, L., Spigel, D. R., Antonia, S. J., Rizvi, N. A., Powderly, J. D., Heist, R. S., Carvajal, R. D., Jackman, D. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3708 · Cited by 1,177
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
History of myeloid-derived suppressor cells
Talmadge, J. E., & Gabrilovich, D. I. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3581 · Cited by 1,148
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962 · cited 1×
“Hypoxia-inducible factor (HIF) which is secreted by TAMs is a key molecule in signaling pathways and plays a critical role in maintaining the hypoxic state and stimulating pro-tumorigenic events [138].”
BackgroundTargeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Dendritic Cells and Cancer Immunity
Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 907
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Ngambenjawong, C., Gustafson, H. H., & Pun, S. H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.010 · Cited by 840
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Kim, J., & Bae, J.-S. (2016) · Mediators of Inflammation · doi:10.1155/2016/6058147 · Cited by 802
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells
Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767
Tumor-associated stromal cells as key contributors to the tumor microenvironment
Bussard, K. M., Mutkus, L., Stumpf, K., Gomez-Manzano, C., & Marini, F. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0740-2 · Cited by 746
Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Min, Y., Roche, K. C., Tian, S., Eblan, M. J., McKinnon, K. P., Caster, J. M., Chai, S., Herring, L. E., Zhang, L., Zhang, T., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.113 · Cited by 701
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695 · cited 1×
“Several nanodrugs, such as Doxil [25] and Abraxane [26], have been approved by the FDA for clinical use.”
BackgroundMacrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Self-citationSong, M., Liu, T., Shi, C., Zhang, X., & Chen, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 662
Doedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
B cell regulation in cancer and anti-tumor immunity
Sarvaria, A., Madrigal, J. A., & Saudemont, A. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.35 · Cited by 630
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 608
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C., Fu, Y.-X., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 596
Gao, M., Liang, C., Song, X., Chen, Q., Jin, Q., Wang, C., & Liu, Z. (2017) · Advanced Materials · doi:10.1002/adma.201701429 · Cited by 590
Song, G., Liang, C., Yi, X., Zhao, Q., Cheng, L., Yang, K., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201504617 · Cited by 587
Improving immune–vascular crosstalk for cancer immunotherapy
Huang, Y., Kim, B. Y. S., Chan, C. K., Hahn, S. M., Weissman, I. L., & Jiang, W. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.145 · Cited by 563
Yuan, Y., Mao, C., Du, X., Du, J., Wang, F., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202296 · Cited by 529
Du, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907210 · Cited by 520
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Li, W.-P., Su, C.-H., Chang, Y.-C., Lin, Y.-J., & Yeh, C.-S. (2016) · ACS Nano · doi:10.1021/acsnano.5b06175 · Cited by 437
Ishii, G., Ochiai, A., & Neri, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.007 · Cited by 434
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
Fransen, M. F., Schoonderwoerd, M., Knopf, P., Camps, M. G. M., Hawinkels, L. J. A. C., Kneilling, M., van Hall, T., & Ossendorp, F. (2018) · JCI Insight · doi:10.1172/jci.insight.124507 · Cited by 427
Tumor Microenvironment and Differential Responses to Therapy
Hirata, E., & Sahai, E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026781 · Cited by 422
Deng, G., Sun, Z., Li, S., Peng, X., Li, W., Zhou, L., Ma, Y., Gong, P., & Cai, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05292 · Cited by 416
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Uy, G. L., Rettig, M. P., Motabi, I. H., McFarland, K., Trinkaus, K. M., Hladnik, L. M., Kulkarni, S., Abboud, C. N., Cashen, A. F., Stockerl-Goldstein, K. E., et al. (2012) · Blood · doi:10.1182/blood-2011-10-383406 · Cited by 400
Overchuk, M., & Zheng, G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.024 · Cited by 383
Stimuli-responsive nanoparticles for targeting the tumor microenvironment
Du, J., Lane, L. A., & Nie, S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.050 · Cited by 382
Cancer prevention and therapy through the modulation of the tumor microenvironment
Casey, S. C., Amedei, A., Aquilano, K., Azmi, A. S., Benencia, F., Bhakta, D., Bilsland, A. E., Boosani, C. S., Chen, S., Ciriolo, M. R., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.007 · Cited by 372
Vascular Permeability and Drug Delivery in Cancers
Azzi, S., Hebda, J. K., & Gavard, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00211 · Cited by 356
Wang, C., Cheng, L., Liu, Y., Wang, X., Ma, X., Deng, Z., Li, Y., & Liu, Z. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201202992 · Cited by 355
Airley, R. E., & Mobasheri, A. (2007) · Chemotherapy · doi:10.1159/000104457 · Cited by 342
Ni, K., Lan, G., Chan, C., Quigley, B., Lu, K., Aung, T., Guo, N., La Riviere, P., Weichselbaum, R. R., & Lin, W. (2018) · Nature Communications · doi:10.1038/s41467-018-04703-w · Cited by 336
Qian, Y., Qiao, S., Dai, Y., Xu, G., Dai, B., Lu, L., Yu, X., Luo, Q., & Zhang, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b05465 · Cited by 333
Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
Ni, K., Lan, G., Veroneau, S. S., Duan, X., Song, Y., & Lin, W. (2018) · Nature Communications · doi:10.1038/s41467-018-06655-7 · Cited by 329
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Guo, S., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25720 · Cited by 315
Stromal Cells in the Tumor Microenvironment
Denton, A. E., Roberts, E. W., & Fearon, D. T. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-78127-3_6 · Cited by 306
Maity, A. M., Pore, N., Lee, J. S. H., Solomon, D., & O’Rourke, D. M. (2000) · PubMed · Cited by 302
Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers
Li, Y., Xiao, K., Zhu, W., Deng, W., & Lam, K. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.008 · Cited by 292
Dong, Z., Feng, L., Zhu, W., Sun, X., Gao, M., Zhao, H., Chao, Y., & Liu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.025 · Cited by 284
Rosalia, R. A., Cruz, L. J., van Duikeren, S., Tromp, A. T., Silva, A. L., Jiskoot, W., de Gruijl, T., Löwik, C., Oostendorp, J., van der Burg, S. H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.053 · Cited by 269
Bruton’s Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Weber, A. N. R., Bittner, Z., Liu, X., Dang, T.-M., Radsak, M. P., & Brunner, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01454 · Cited by 269
Zhao, Y., Luo, Z., Li, M., Qu, Q., Ma, X., Yu, S., & Zhao, Y. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408510 · Cited by 263
Gold nanoparticles enlighten the future of cancer theranostics
Guo, J., Rahme, K., He, Y., Li, L.-L., Holmes, J., & O'Driscoll, C. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s140772 · Cited by 260
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Drug-incorporating calcium carbonate nanoparticles for a new delivery system
Ueno, Y., Futagawa, H., Takagi, Y., Ueno, A., & Mizushima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.015 · Cited by 254
Alili, L., Sack, M., Karakoti, A. S., Teuber, S., Puschmann, K., Hirst, S. M., Reilly, C. M., Zanger, K., Stahl, W., Das, S., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.056 · Cited by 249
Zhao, P., Wang, Y., Kang, X., Wu, A., Yin, W., Tang, Y., Wang, J., Zhang, M., Duan, Y., & Huang, Y. (2018) · Chemical Science · doi:10.1039/c7sc04853j · Cited by 248
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Yu, X., Dai, Y., Zhao, Y., Qi, S., Liu, L., Lu, L., Luo, Q., & Zhang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-14906-9 · Cited by 243
Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
Musetti, S., & Huang, L. (2018) · ACS Nano · doi:10.1021/acsnano.8b05893 · Cited by 239
Song, G., Ji, C., Liang, C., Song, X., Yi, X., Dong, Z., Yang, K., & Liu, Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.020 · Cited by 238
Cruz, L. J., Rosalia, R. A., Kleinovink, J. W., Rueda, F., Löwik, C. W. G. M., & Ossendorp, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.040 · Cited by 235
Perfluorocarbon-based oxygen carriers: from physics to physiology
Jägers, J., Wrobeln, A., & Ferenz, K. B. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02482-2 · Cited by 233
Arvizo, R. R., Rana, S., Miranda, O. R., Bhattacharya, R., Rotello, V. M., & Mukherjee, P. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.01.011 · Cited by 229
Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics
Chen, Q., Liu, G., Liu, S., Su, H., Wang, Y., Li, J., & Luo, C. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.10.009 · Cited by 229
Self-citationDendritic cell-based immunotherapy: a basic review and recent advances
Constantino, J., Gomes, C., Falcão, A., Neves, B. M., & Cruz, M. T. (2017) · Immunologic Research · doi:10.1007/s12026-017-8931-1 · Cited by 228
Zhen, Z., Tang, W., Wang, M., Zhou, S., Wang, H., Wu, Z., Hao, Z., Li, Z., Liu, L., & Xie, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04150 · Cited by 219
Ji, T., Zhao, Y., Ding, Y., Wang, J., Zhao, R., Lang, J., Qin, H., Liu, X., Shi, J., Tao, N., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201506262 · Cited by 215
Kim, H., Niu, L., Larson, P., Kucaba, T. A., Murphy, K. A., James, B. R., Ferguson, D. M., Griffith, T. S., & Panyam, J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.034 · Cited by 210
Enhancement of radiation effect by heavy elements
Kobayashi, K., Usami, N., Porcel, E., Lacombe, S., & Le Sech, C. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.002 · Cited by 202
Du, J.-Z., Mao, C.-Q., Yuan, Y.-Y., Yang, X.-Z., & Wang, J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.002 · Cited by 202
Targeting tumor antigens to dendritic cells using particulate carriers
Joshi, M. D., Unger, W. J., Storm, G., van Kooyk, Y., & Mastrobattista, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.010 · Cited by 196
WU, G., LUO, J., RANA, J., LAHAM, R., SELLKE, F., & LI, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.09.019 · Cited by 196
Self-citationEnhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Jeanbart, L., Ballester, M., de Titta, A., Corthésy, P., Romero, P., Hubbell, J. A., & Swartz, M. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0019-t · Cited by 191
PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
Ruf, M., Moch, H., & Schraml, P. (2016) · International Journal of Cancer · doi:10.1002/ijc.30077 · Cited by 179
Endothelial cell phagokinesis in response to specific metal ions
McAuslan, B. R., & Reilly, W. (1980) · Experimental Cell Research · doi:10.1016/0014-4827(80)90051-8 · Cited by 175
Cancer-associated fibroblasts in hepatocellular carcinoma
Kubo, N., Araki, K., Kuwano, H., & Shirabe, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6841 · Cited by 173
Liang, R., Xie, J., Li, J., Wang, K., Liu, L., Gao, Y., Hussain, M., Shen, G., Zhu, J., & Tao, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.029 · Cited by 173
Self-citationZhao, Y., Luo, Z., Li, M., Qu, Q., Ma, X., Yu, S., & Zhao, Y. (2015) · Angewandte Chemie · doi:10.1002/ange.201408510 · Cited by 173
Feng, L., Li, K., Shi, X., Gao, M., Liu, J., & Liu, Z. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300549 · Cited by 171
Cuccarese, M. F., Dubach, J. M., Pfirschke, C., Engblom, C., Garris, C., Miller, M. A., Pittet, M. J., & Weissleder, R. (2017) · Nature Communications · doi:10.1038/ncomms14293 · Cited by 168
Microenvironment and Radiation Therapy
Yoshimura, M., Itasaka, S., Harada, H., & Hiraoka, M. (2012) · BioMed Research International · doi:10.1155/2013/685308 · Cited by 163
Coordination bonding based pH-responsive drug delivery systems
Zheng, H., Xing, L., Cao, Y., & Che, S. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.03.007 · Cited by 159
Kang, S., Ahn, S., Lee, J., Kim, J. Y., Choi, M., Gujrati, V., Kim, H., Kim, J., Shin, E.-C., & Jon, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.024 · Cited by 159
Tumour angiogenesis—Origin of blood vessels
Krishnapriya, S., Nagare, R. P., Sneha, V. S., Sidhanth, C., Bindhya, S., Manasa, P., & Ganesan, T. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30067 · Cited by 156
Lebbé, C., Weber, J. S., Maio, M., Neyns, B., Harmankaya, K., Hamid, O., O'Day, S. J., Konto, C., Cykowski, L., McHenry, M. B., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu441 · Cited by 152
Muraoka, D., Harada, N., Hayashi, T., Tahara, Y., Momose, F., Sawada, S., Mukai, S., Akiyoshi, K., & Shiku, H. (2014) · ACS Nano · doi:10.1021/nn502975r · Cited by 151
Im, S., Lee, J., Park, D., Park, A., Kim, Y., & Kim, W. J. (2018) · ACS Nano · doi:10.1021/acsnano.8b07045 · Cited by 146
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Chen, Y., Liu, X., Yuan, H., Yang, Z., Roemeling, C. A. V., Qie, Y., Hai, Z., Wang, Y., Jiang, W., & Kim, B. Y. S. (2019) · Advanced Science · doi:10.1002/advs.201802070 · Cited by 142
Nanoscale Metal–Organic Layers for Radiotherapy–Radiodynamic Therapy
Lan, G., Ni, K., Veroneau, S. S., Song, Y., & Lin, W. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11593 · Cited by 139
Li, L., Sun, W. Y., Zhong, J., Yang, Q., Zhu, X. D., Zhou, Z., Zhang, Z., & Huang, Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501248 · Cited by 135
Zhou, P., Qin, J., Zhou, C., Wan, G., Liu, Y., Zhang, M., Yang, X., Zhang, N., & Wang, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.007 · Cited by 125
Tumor-associated fibroblasts (part II): Functional impact on tumor tissue.
Kunz‐Schughart, L. A., & Knuechel, R. (2002) · PubMed · doi:10.14670/hh-17.623 · Cited by 124
Mardhian, D. F., Storm, G., Bansal, R., & Prakash, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.031 · Cited by 123
Luo, L., Iqbal, M. Z., Chuang, L. I. U., Xing, J., Akakuru, O. U., Fang, Q., Li, Z., Dai, Y., Li, A., Guan, Y., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119464 · Cited by 115
Zhao, H., Zhao, B., Wu, L., Xiao, H., Ding, K., Zheng, C., Song, Q., Sun, L., Wang, L., & Zhang, Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b03288 · Cited by 112
Macrophages and Fibroblasts, Key Players in Cancer Chemoresistance
Ireland, L., & Mielgo, A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00131 · Cited by 111
Chen, Q., Xu, L., Chen, J., Yang, Z., Liang, C., Yang, Y., & Liu, Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.021 · Cited by 104
Song, L., Smith, M. A., Doshi, P. D., Sasser, K., Fulp, W. J., Altiok, S., & Haura, E. B. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000193 · Cited by 104
Qiu, Q., Li, C., Song, Y., Shi, T., Luo, X., Zhang, H., Hu, L., Yan, X., Zheng, H., Liu, M., et al. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.030 · Cited by 103
Pericytes on the Tumor Vasculature: Jekyll or Hyde?
Barlow, K. D., Sanders, A. M., Söker, S., Ergün, S., & Metheny‐Barlow, L. J. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0102-2 · Cited by 99
Kang, T., Huang, Y., Zhu, Q., Cheng, H., Pei, Y., Feng, J., Xu, M., Jiang, G., Song, Q., Jiang, T., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.033 · Cited by 99
Chen, B., Wang, Z., Sun, J., Song, Q., He, B., Zhang, H., Wang, X., Dai, W., & Zhang, Q. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.001 · Cited by 97
Ai, X., Hu, M., Wang, Z., Lyu, L., Zhang, W., Li, J., Yang, H., Lin, J., & Xing, B. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00068 · Cited by 96
Self-citationTruffi, M., Mazzucchelli, S., Bonizzi, A., Sorrentino, L., Allevi, R., Vanna, R., Morasso, C., & Corsi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061263 · Cited by 94
Vascular disrupting agents in cancer therapy
Smolarczyk, R., Czapla, J., Jarosz–Biej, M., Czerwinski, K., & Cichoń, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173692 · Cited by 92
Li, Y., Ayala‐Orozco, C., Rauta, P. R., & Krishnan, S. (2019) · Nanoscale · doi:10.1039/c9nr05371a · Cited by 88
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
Rotman, J., Koster, B. D., Jordanova, E. S., Heeren, A. M., & de Gruijl, T. D. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02330-y · Cited by 83
Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy
Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82
Silva, V. L., & Al-Jamal, W. T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.013 · Cited by 82
Rajendrakumar, S. K., Uthaman, S., Cho, C.-S., & Park, I. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00460 · Cited by 82
Li, L., Zhou, S., Lv, N., Zhen, Z., Liu, T., Gao, S., Xie, J., & Ma, Q. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00419 · Cited by 78
Podar, K., Zimmerhackl, A., Fulciniti, M., Tonon, G., Hainz, U., Tai, Y., Vallet, S., Halama, N., Jäger, D., Olson, D. L., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08864.x · Cited by 76
Zhou, Z., Kennell, C., Jafari, M., Lee, J., Ruiz-Torres, S. J., Waltz, S. E., & Lee, J.-H. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.085 · Cited by 69
Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?
Mattheolabakis, G., & Mikelis, C. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01227 · Cited by 68
He, X., Liu, B., Wu, J., Ai, S., Zhuo, R., & Cheng, S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b13594 · Cited by 65
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
Liu, Q., Zhu, H., Liu, Y., Musetti, S., & Huang, L. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-2079-7 · Cited by 62
Du, S. M., Xiong, H., Xu, C., Lu, Y., & Yao, J. (2019) · Biomaterials Science · doi:10.1039/c8bm01350k · Cited by 62
Li, S., Bennett, Z. T., Sumer, B. D., & Gao, J. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00475 · Cited by 57
Targeting Immunotherapy to the Tumor Microenvironment
Dougan, M. L., & Dougan, S. K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26005 · Cited by 55
Nanoparticles designed to regulate tumor microenvironment for cancer therapy
Li, M., Zhang, F., Su, Y., Zhou, J., & Wang, W. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.03.044 · Cited by 54
Dominguez, A. L., & Lustgarten, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.153 · Cited by 50
TUMOR-ASSOCIATED ANTIGENS: FROM DISCOVERY TO IMMUNITY
Lewis, J. D., Reilly, B. D., & Bright, R. K. (2003) · International Reviews of Immunology · doi:10.1080/08830180305221 · Cited by 49
Hatzioannou, A., Alissafi, T., & Verginis, P. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5vmr1116-493r · Cited by 49
Zhou, Y., Miao, J., Wu, H., Tang, H., Kuang, J., Zhou, X., Peng, Y., Hu, D., Shi, D., Deng, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17214 · Cited by 47
Effect of Fe3O4Nanoparticles on Skin Tumor Cells and Dermal Fibroblasts
Alili, L., Chapiro, S., Marten, G. U., Schmidt, A. M., Zanger, K., & Brenneisen, P. (2015) · BioMed Research International · doi:10.1155/2015/530957 · Cited by 36
Combining vasculature disrupting agent and toll-like receptor 7/8 agonist for cancer therapy
Seth, A., Lee, H., Cho, M. Y., Park, C.-S., Korm, S., Lee, J., Choi, I., Lim, Y. T., & Hong, K. S. (2016) · Oncotarget · doi:10.18632/oncotarget.14260 · Cited by 35
Nath, A., Pal, R., Singh, L. M., Saikia, H., Rahaman, H., Ghosh, S. K., Mazumder, R., & Sengupta, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.02.021 · Cited by 30
Liao, X., Zhao, L., Wu, S., Zheng, H., Chen, H., Zhang, H., Wang, Z., & Lin, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.22938 · Cited by 5
Cited by
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Obidiro, O., Battogtokh, G., & Akala, E. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071796 · Cited by 511
Nanozymes-recent development and biomedical applications
Ren, X., Chen, D., Wang, Y., Li, H., Zhang, Y., Chen, H., Li, X., & Huo, M. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01295-y · Cited by 456
Phototherapy in cancer treatment: strategies and challenges
Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Metadata
- Authors
- Yang, M., Li, J., Gu, P., & Fan, X.
- Venue
- Bioactive Materials
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 6
- Issue
- 7
- Pages
- 1973-1987
- ISSN
- 2097-1192 (ISSN-L)
- 2452-199X
- OpenAlex
- W3114344131
- Cited by
- 670
- References
- 156
- FWCI
- 20.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.